Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
All repurchased shares of CBT will be retired and restored to the status of authorized but unissued common stock of the company.
ECPG's third-quarter earnings suffer from rising operating expenses and the competitive environment in the U.K. Improved portfolio purchasing in the United States partially offset the negatives.
The decline in Q4 EBIT of CBT's Reinforcement Material segment is due to reduced volumes in the Americas, a less advantageous regional mix and higher costs.
Cabot Corporation (NYSE:CBT ) Q4 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Steve Delahunt - Vice President, Treasurer & Investor Relations Sean Keohane - Chief Executive Officer & President Erica McLaughlin - Executive Vice President & Chief Financial Officer Conference Call Participants John Roberts - Mizuho Chris Perrella - UBS Jeff Zekauskas - JPMorgan Dan Rizzo - Jefferies Operator Good day, everyone, and thank you for standing by. Welcome to the Fourth Quarter 2024 Cabot Earnings Conference Call.
Cabot (CBT) came out with quarterly earnings of $1.80 per share, missing the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.65 per share a year ago.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors interested in stocks from the Chemical - Diversified sector have probably already heard of Cabot (CBT) and Air Products and Chemicals (APD). But which of these two stocks is more attractive to value investors?
Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, FMC and CBT are poised to navigate the industry challenges.